| Indicators | Browse All

Alpha Teknova, Inc. (TKNO)

Healthcare | Drug Manufacturers - Specialty & Generic | Hollister, United States | NasdaqGM
5.41 USD +0.05 (0.933%) ⇧ (July 13, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4 a.m. EDT

Alpha Teknova presents a stark dichotomy between a fundamentally broken business and a speculative trading opportunity. The long-term outlook is severely compromised; the company has endured four consecutive years of massive value destruction, dropping nearly 80% from its peak, while burning through cash with negative free cash flow and a negative operating margin. Despite a recent price rebound, the underlying fundamentals—negative earnings, deteriorating returns on equity, and a lack of sustainable profitability—justify a 'avoid' rating for any investor seeking capital preservation or steady growth. However, the short-term picture tells a different story driven purely by sentiment and technicals. The stock has rallied significantly from its lows, and the options market reflects a 'long gamma' environment where traders are betting on volatility expansion rather than immediate direction. The heavy put wall at $2.50 acts as a psychological floor, while the $10 call activity hints at hopes for a catalyst. For a trader, this is a volatile, high-risk setup where the price could bounce off support or continue its grind lower; for a fundamental investor, the business quality is currently non-existent.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.298141
MSTL0.304022
AutoTheta0.308920
AutoARIMA0.310346

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 30%
H-stat 12.31
Ljung-Box p 0.000
Jarque-Bera p 0.187
Excess Kurtosis -1.31
Attribute Value
Sector Healthcare
Debt to Equity Ratio 42.861
Revenue per Share 0.781
Market Cap 290,051,872
Forward P/E -22.08
Beta 0.63
Profit Margins -41.07%
Website https://www.teknova.com

As of July 11, 2026, 4 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at the $2.50 strike, creating a significant barrier at the 52-week low. Conversely, there is notable call interest at the $10.00 strike for the December expiration, suggesting a speculative bet on a potential recovery to near-recovery highs, though immediate-term call activity remains thin.


Info Dump

Attribute Value
52 Week Change 0.19376397
Address1 2,451 Bert Dr.
All Time High 30.89
All Time Low 1.155
Ask 6.8
Ask Size 2
Audit Risk 4
Average Daily Volume10 Day 182,730
Average Daily Volume3 Month 168,124
Average Volume 168,124
Average Volume10Days 182,730
Beta 0.627
Bid 3.9
Bid Size 2
Board Risk 10
Book Value 1.211
City Hollister
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 8
Country United States
Crypto Tradeable 0
Currency USD
Current Price 5.41
Current Ratio 4.593
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 5.48
Day Low 5.25
Debt To Equity 42.861
Display Name Alpha Teknova
Earnings Call Timestamp End 1,778,104,800
Earnings Call Timestamp Start 1,778,104,800
Earnings Timestamp 1,785,960,000
Earnings Timestamp End 1,785,960,000
Earnings Timestamp Start 1,785,960,000
Ebitda -9,472,000
Ebitda Margins -0.22659001
Enterprise To Ebitda -31.682
Enterprise To Revenue 7.179
Enterprise Value 300,094,880
Eps Current Year -0.325
Eps Forward -0.245
Eps Trailing Twelve Months -0.31
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 4.5584
Fifty Day Average Change 0.8515997
Fifty Day Average Change Percent 0.18681987
Fifty Two Week Change Percent 19.376396
Fifty Two Week High 6.68
Fifty Two Week High Change -1.27
Fifty Two Week High Change Percent -0.19011976
Fifty Two Week Low 1.91
Fifty Two Week Low Change 3.5
Fifty Two Week Low Change Percent 1.8324608
Fifty Two Week Range 1.91 - 6.68
Financial Currency USD
First Trade Date Milliseconds 1,624,627,800,000
Float Shares 10,879,895
Forward Eps -0.245
Forward P E -22.08163
Free Cashflow -2,387,875
Full Exchange Name NasdaqGM
Full Time Employees 158
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.34013
Gross Profits 14,218,000
Has Pre Post Market Data 1
Held Percent Insiders 0.093219995
Held Percent Institutions 0.84726995
Implied Shares Outstanding 53,614,028
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Ipo Expected Date 2,021-06-25
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.
Long Name Alpha Teknova, Inc.
Market us_market
Market Cap 290,051,872
Market State PRE
Max Age 86,400
Message Board Id finmb_116531601
Most Recent Quarter 1,774,915,200
Net Income To Common -17,169,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 290,051,891
Number Of Analyst Opinions 3
Open 5.3
Operating Cashflow -7,902,000
Operating Margins -0.38801
Overall Risk 9
Payout Ratio 0.0
Phone 831 637 1100
Previous Close 5.36
Price Eps Current Year -16.646154
Price Hint 2
Price To Book 4.4673824
Price To Sales Trailing12 Months 6.938708
Profit Margins -0.41072
Quick Ratio 3.401
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0499997
Regular Market Change Percent 0.93283
Regular Market Day High 5.48
Regular Market Day Low 5.25
Regular Market Day Range 5.25 - 5.48
Regular Market Open 5.3
Regular Market Previous Close 5.36
Regular Market Price 5.41
Regular Market Time 1,783,972,800
Regular Market Volume 207,542
Return On Assets -0.092930004
Return On Equity -0.23923999
Revenue Growth 0.131
Revenue Per Share 0.781
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 53,614,028
Shares Percent Shares Out 0.0233
Shares Short 1,251,824
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 1,109,886
Short Name Alpha Teknova, Inc.
Short Percent Of Float 0.114700004
Short Ratio 5.02
Source Interval 15
State CA
Symbol TKNO
Target High Price 12.0
Target Low Price 7.0
Target Mean Price 9.0
Target Median Price 8.0
Total Cash 17,784,000
Total Cash Per Share 0.332
Total Debt 27,827,000
Total Revenue 41,802,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.31
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.0125
Two Hundred Day Average Change 1.3975
Two Hundred Day Average Change Percent 0.34828663
Type Disp Equity
Volume 207,542
Website https://www.teknova.com
Zip 95,023